ArticleFrontiers in oncology2026
Brachytherapy-based multimodality cancer treatment: a concept and design perspective on devices to address the challenges of localized radiation therapy.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To present a family of novel brachytherapy-based device concepts that address the geometric, dosimetric, and integrative limitations of current localized radiation therapy, aiming to improve local tumor control while reducing collateral exposure. This is a concept and design paper, not a clinical or dosimetric validation study. Methods: Multiple device designs were developed over more than a decade, focused on two prototypical clinical settings: intraluminal applicators for the esophagus and intracavitary applicators for the post-resection glioblastoma cavity. Designs include hollow rectangular ribbon (HRR) catheters that encase fluid, gel, or wire isotope sources; modified stents with anti-slippage geometry, dynamic flares, and reservoirs; and a multifunctional cavity device combining brachytherapy with continuous hyperthermia and pressure-modulated diffusional drug, immunotherapy, and nanoparticle delivery. Bench prototypes were constructed and evaluated. Results: Bench observations demonstrated manipulation of a thermal gradient by modulating the warm source, and an approximately 15-fold increase in dislodgement force for a representative anti-slippage geometry. The designs are further intended to flatten the near-surface dose gradient by expanding the effective source distribution and to integrate drainage, infusion, and pressure modulation in a single device; these dosimetric and integrative benefits are design expectations not yet experimentally tested. Conclusion: These concepts may improve local control where recurrence concentrates near the resection or stented surface, as in post-resection glioblastoma and obstructive luminal malignancies. The integration of continuous hyperthermia, local diffusion of chemotherapeutic, immunotherapeutic, and protective agents, and pressure-modulated nanoparticle delivery is particularly attractive. The concepts are intended to stimulate further bench, computational, animal, and clinical investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.